Vertex Pharmaceuticals (VRTX) returns
Vertex Pharmaceuticals returns over 10 years
$1,000 invested in Vertex Pharmaceuticals ten years ago was worth $7,204 at the close on October 30, 2026, with dividends reinvested: an average return of 21.8% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.9% | — | $1,069 | -0.9% |
| 3 months | +16.0% | — | $1,160 | +2.1% |
| Year to date | +23.3% | — | $1,233 | +11.7% |
| 1 year | +33.1% | — | $1,331 | +12.4% |
| 3 years | +56.4% | +16.1% | $1,564 | +88.5% |
| 5 years | +202.2% | +24.8% | $3,022 | +76.0% |
| 10 years | +620.4% | +21.8% | $7,204 | +316.6% |
Vertex Pharmaceuticals return by calendar year
| Year | VRTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +23.3% | +11.7% | +11.6% |
| 2025 | +12.6% | +17.7% | -5.1% |
| 2024 | -1.0% | +24.9% | -25.9% |
| 2023 | +40.9% | +26.2% | +14.7% |
| 2022 | +31.5% | -18.2% | +49.7% |
| 2021 | -7.1% | +28.7% | -35.8% |
| 2020 | +7.9% | +18.4% | -10.4% |
| 2019 | +32.1% | +31.2% | +0.9% |
| 2018 | +10.6% | -4.6% | +15.1% |
| 2017 | +103.4% | +21.7% | +81.7% |
| 2016 | -41.5% | +12.0% | -53.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: VRTX financials · VRTX valuation
No forecast, no recommendation. This page describes Vertex Pharmaceuticals from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.